Sun Biopharma Inc. | |
Stock Exchange | Other OTC |
EPS |
$1.2 |
Market Cap |
$13.13 M |
Shares Outstanding |
5.07 M |
Public Float |
3.01 M |
Address |
712 Vista Boulevard Waconia Minnesota 55387 United States |
Employees | - |
Website | http://www.sunbiopharma.com |
Updated | 07/08/2019 |
Sun BioPharma Inc. is a clinical-stage biopharmaceutical company, which engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan in 2011 and is headquartered in Waconia, MN. |